TENAX THERAPEUTICS, INC. Accumulated Other Comprehensive Income
TENAX THERAPEUTICS, INC. (TENX) had Accumulated Other Comprehensive Income of $0 as of 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-03-29
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2021-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.00.
- 2021-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$274.00.
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$402.00.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-29 |
| 2021-09-30 | $2.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$274.00 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$402.00 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$70.00 10-K · filed 2022-03-29 |
| 2020-09-30 | $903.00 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.07K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$1.16K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $458.00 10-K/A · filed 2021-04-16 |
| 2019-09-30 | $1.32K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.28K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.80K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $516.00 10-K · filed 2020-03-30 |
| 2018-09-30 | -$9.98K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$16.50K 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$27.05K 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$16.19K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$5.75K 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$9.52K 10-Q · filed 2017-08-09 |
| 2017-03-31 | -$12.18K 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$18.72K 10-K · filed 2018-04-02 |
| 2016-09-30 | $49.54K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $88.87K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $10.79K 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$129.44K 10-K · filed 2017-03-16 |
| 2015-10-31 | -$17.87K 10-Q · filed 2015-12-10 |
| 2015-07-31 | -$39.16K 10-Q · filed 2015-09-09 |
| 2015-04-30 | $26.72K 10-KT · filed 2016-03-14 |
| 2015-01-31 | $53.43K 10-Q · filed 2015-03-17 |
| 2014-10-31 | -$42.31K 10-Q · filed 2014-12-15 |
| 2014-07-31 | -$65.56K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $0.00 10-K · filed 2015-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |